EUVIMEDEUVIMED entdecken
Crossref

Mapping the Metabolic Fate of Suzetrigine in Equine and Camel Models: A Step Toward Reliable Antidoping Detection

Shino Ann Koshy, Meleparappil Muhammed Ajeebsanu, Abdul Khader Karakka Kal iD, Michael Benedict Subhahar, Tajudheen K Karatt, Moses Philip

Rapid Communications in Mass Spectrometry · 2026-01 · 40 (1)

DOI: 10.1002/rcm.10147 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rapid Communications in Mass Spectrometry, online erschienen am 30.09.2025. Verfasst von Shino Ann Koshy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Equine Forensic Unit, Central Veterinary Research Laboratory, Dubai, UAE. Hauptthemen laut MEDLINE: Doping in Sports, Substance Abuse Detection. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

Effective pain management remains a persistent challenge, with opioids limited by tolerance, dependence, respiratory depression, and misuse. This has created demand for safer, nonaddictive alternatives. Suzetrigine (VX‐548, Journavx) is a novel analgesic with promising efficacy, but its potential misuse in competitive racing requires investigation. Limited information is available on its metabolism and detection, emphasizing the need for metabolic characterization to aid antidoping strategies.

Methods

In vitro metabolism of suzetrigine was evaluated using equine liver microsomes and homogenized camel liver. Metabolic profiling was carried out using high‐resolution LC–HRMS. Fragmentation analysis was performed to assign metabolite structures and characterize biotransformation pathways.

Results

Seven phase I metabolites (M1–M7) were identified, primarily via hydroxylation, methylation, demethylation, detrifluoromethylation, and cleavage of the pyridine‐2‐carboxamide moiety. One phase II metabolite (M8), formed by sulfation of the demethylated metabolite M5, was detected exclusively with camel liver. Metabolite structures were tentatively assigned based on mass fragmentation data, which showed characteristic neutral losses and diagnostic ions. Comparative analysis revealed that both species shared common phase I pathways, but camel liver demonstrated additional conjugation capacity.

Conclusion

This study provides the first comprehensive characterization of suzetrigine metabolism in equine and camel liver systems. The results underscore metabolic variations, propose a biotransformation pathway, and offer crucial insights to support the development of antidoping detection strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Doping in SportsSubstance Abuse DetectionAnimalsHorsesMicrosomes, LiverCamelusChromatography, LiquidLiver

Stichwörter der Autor:innen

LC‐HRMS analysisNaV1.8 sodium channel modulatorantidoping detectioncamel liverequine liver microsomesin vitrosuzetrigine

Autor:innen und Institutionen

  • Equine Forensic Unit, Central Veterinary Research Laboratory, Dubai, UAE.

ORCID-Profile: Abdul Khader Karakka Kal

Zitieren

APA

Koshy, S. A., Ajeebsanu, M. M., Karakka Kal, A. K., Subhahar, M. B., Karatt, T. K., & Philip, M. (2026). Mapping the Metabolic Fate of Suzetrigine in Equine and Camel Models: A Step Toward Reliable Antidoping Detection. Rapid Communications in Mass Spectrometry, 40(1). https://doi.org/10.1002/rcm.10147

Vancouver

Koshy SA, Ajeebsanu MM, Karakka Kal AK, Subhahar MB, Karatt TK, Philip M. Mapping the Metabolic Fate of Suzetrigine in Equine and Camel Models: A Step Toward Reliable Antidoping Detection. Rapid Communications in Mass Spectrometry. 2026;40(1). doi:10.1002/rcm.10147

BibTeX
@article{Koshy2026,
  author = {Koshy, Shino Ann and Ajeebsanu, Meleparappil Muhammed and Karakka Kal, Abdul Khader and Subhahar, Michael Benedict and Karatt, Tajudheen K and Philip, Moses},
  title = {Mapping the Metabolic Fate of Suzetrigine in Equine and Camel Models: A Step Toward Reliable Antidoping Detection},
  journal = {Rapid Communications in Mass Spectrometry},
  year = {2026},
  volume = {40},
  number = {1},
  doi = {10.1002/rcm.10147}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche